pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
NOVO · news · pharmadog
← back to NOVO
News mentioning NOVO
476
stories
Sep 24, 26
FDA slams GLP-1 compounder over risk of contaminating drugs ‘with filth’
biospace
Sep 24, 26
FDA approves Eli Lilly's once-weekly insulin pen, setting up rivalry with Novo
endpoints
Sep 24, 26
STAT+: Indonesian ruling against ‘patent evergreening’ by pharma industry sends critical message, patient advocates say
stat
Sep 24, 26
Eli Lilly’s weekly insulin shot cleared by FDA, setting up another front in Novo rivalry
biospace
Sep 24, 26
Opinion: STAT+: A moment of reckoning for preventive cardiology and the precision medicine revolution
stat
Sep 24, 26
STAT+: Trump boast on drug pricing policy overstated state-level interest in federal program
stat
Sep 24, 26
STAT+: Momentum is building for a big change to how doctors get paid
stat
Sep 23, 26
STAT+: Nominee to lead FDA aims to speed up medical research, combat China’s rise
stat
Sep 23, 26
STAT+: FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks
stat
Sep 23, 26
9 pharma leaders sound ‘alarm bells’ on biotech’s decline in Europe
biopharma dive
Sep 23, 26
STAT+: Flagship gets a Pentagon contract
stat
Sep 23, 26
STAT+: Pharmalittle: We’re reading about a closing loophole for importing meds, European competitiveness, and more
stat
Sep 23, 26
Novo’s turnaround plan, weight loss wins, Ultragenyx’s Sanfilippo approval, IPO blitz
biospace
Sep 23, 26
STAT+: A private equity-owned hospital chain is becoming a nonprofit. Is it just a bailout for investors?
stat
Sep 23, 26
STAT+: Drugmakers, biotech VCs show ‘reinvigorated’ interest in osteoporosis treatments
stat
Sep 22, 26
STAT+: HHS unveils new initiatives to reduce animal testing in drug development
stat
Sep 22, 26
Novo's CEO knows the drugmaker needs to build confidence
endpoints
Sep 22, 26
STAT+: Did the Trump administration just cut Novo a huge financial win?
stat
Sep 22, 26
Viking shares surge on updated obesity drug data
biopharma dive
Sep 22, 26
Viking achieves 'maintenance trifecta' as GLP-1/GIP dual agonist exceeds expectations
biospace
Sep 22, 26
Novo targets 10-fold jump in oral Wegovy manufacturing capacity by 2030
biospace
Sep 22, 26
STAT+: Novo may be getting a better deal than expected with Medicare’s Bridge program
stat
Sep 22, 26
Novo’s workforce reduction climbs to 13,000 to fuel R&D work
biospace
Sep 22, 26
Roche’s Carmot asset normalizes blood sugar, cuts weight in Phase 2 diabetes trial
biospace
Sep 22, 26
STAT+: Pharmalittle: We’re reading about pharma seeking to protect China deals, a Roche obesity drug, and more
stat
Sep 22, 26
Siemens Healthineers and Novo team up on fatty liver disease awareness, testing
fiercebiotech
Sep 22, 26
Roche’s GLP-1/GIP drug hits in phase 2 diabetes trial, fueling best-in-disease hopes
fiercebiotech
Sep 21, 26
Novo talks up drug launches in effort to win back investors
biopharma dive
Sep 21, 26
Novo offers low-dose CagriSema data as approval decision looms
endpoints
Sep 21, 26
STAT+: Lilly’s breast cancer combo wins approval
stat
← prev
page 5 of 16
next →
